These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 20803335

  • 1. Wavelength-dependent effect of tetra(m-hydroxyphenyl)chlorin for photodynamic therapy in an 'early' squamous cell carcinoma model.
    Blant SA, Theumann JF, Forrer M, Wagnières G, Van Den Bergh H, Monnier P.
    Lasers Med Sci; 1997 Oct; 12(3):269-73. PubMed ID: 20803335
    [Abstract] [Full Text] [Related]

  • 2. Photodynamic therapy of early squamous cell carcinoma with tetra(m-hydroxyphenyl)chlorin: optimal drug-light interval.
    Andrejevic-Blant S, Hadjur C, Ballini JP, Wagnières G, Fontolliet C, van den Bergh H, Monnier P.
    Br J Cancer; 1997 Oct; 76(8):1021-8. PubMed ID: 9376261
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics and pharmacodynamics of tetra(m-hydroxyphenyl)chlorin in the hamster cheek pouch tumor model: comparison with clinical measurements.
    Glanzmann T, Forrer M, Blant SA, Woodtli A, Grosjean P, Braichotte D, van den Bergh H, Monnier P, Wagnières G.
    J Photochem Photobiol B; 2000 Aug; 57(1):22-32. PubMed ID: 11100834
    [Abstract] [Full Text] [Related]

  • 4. In vivo fluence rate effect in photodynamic therapy of early cancers with tetra(m-hydroxyphenyl)chlorin.
    Blant SA, Woodtli A, Wagnières G, Fontolliet C, van den Bergh H, Monnier P.
    Photochem Photobiol; 1996 Dec; 64(6):963-8. PubMed ID: 8972639
    [Abstract] [Full Text] [Related]

  • 5. Photodynamic therapy for early squamous cell carcinomas of the esophagus, bronchi, and mouth with m-tetra (hydroxyphenyl) chlorin.
    Savary JF, Monnier P, Fontolliet C, Mizeret J, Wagnières G, Braichotte D, van den Bergh H.
    Arch Otolaryngol Head Neck Surg; 1997 Feb; 123(2):162-8. PubMed ID: 9046283
    [Abstract] [Full Text] [Related]

  • 6. Effective treatment of liver metastases with photodynamic therapy, using the second-generation photosensitizer meta-tetra(hydroxyphenyl)chlorin (mTHPC), in a rat model.
    Rovers JP, Saarnak AE, Molina A, Schuitmaker JJ, Sterenborg HJ, Terpstra OT.
    Br J Cancer; 1999 Oct; 81(4):600-8. PubMed ID: 10574244
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics of tetra(m-hydroxyphenyl)chlorin in human plasma and individualized light dosimetry in photodynamic therapy.
    Glanzmann T, Hadjur C, Zellweger M, Grosiean P, Forrer M, Ballini JP, Monnier P, van den Bergh H, Lim CK, Wagnières G.
    Photochem Photobiol; 1998 May; 67(5):596-602. PubMed ID: 9613244
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of a new photosensitizer, meso-tetra-hydroxyphenyl-chlorin, for use in photodynamic therapy: a comparison of its photobiological properties with those of two other photosensitizers.
    Ma L, Moan J, Berg K.
    Int J Cancer; 1994 Jun 15; 57(6):883-8. PubMed ID: 8206681
    [Abstract] [Full Text] [Related]

  • 9. Time-dependent biodistribution of tetra(m-hydroxyphenyl)chlorin and benzoporphyrin derivative monoacid ring A in the hamster model: comparative fluorescence microscopy study.
    Andrejevic Blant S, Ballini JP, van den Bergh H, Fontolliet C, Wagnières G, Monnier P.
    Photochem Photobiol; 2000 Mar 15; 71(3):333-40. PubMed ID: 10732452
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Schedule-dependent interaction between Doxorubicin and mTHPC-mediated photodynamic therapy in murine hepatoma in vitro and in vivo.
    Kirveliene V, Grazeliene G, Dabkeviciene D, Micke I, Kirvelis D, Juodka B, Didziapetriene J.
    Cancer Chemother Pharmacol; 2006 Jan 15; 57(1):65-72. PubMed ID: 16001168
    [Abstract] [Full Text] [Related]

  • 12. Photosensitization of isolated rat liver mitochondria by tetra(m-hydroxyphenyl)chlorin.
    Klein SD, Walt H, Richter C.
    Arch Biochem Biophys; 1997 Dec 15; 348(2):313-9. PubMed ID: 9434743
    [Abstract] [Full Text] [Related]

  • 13. Effect of meta-tetra(hydroxyphenyl)chlorin (mTHPC)-mediated photodynamic therapy on sensitive and multidrug-resistant human breast cancer cells.
    Teiten MH, Bezdetnaya L, Merlin JL, Bour-Dill C, Pauly ME, Dicato M, Guillemin F.
    J Photochem Photobiol B; 2001 Sep 15; 62(3):146-52. PubMed ID: 11566278
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Photodynamic therapy with chlorins for diffuse malignant mesothelioma: initial clinical results.
    Ris HB, Altermatt HJ, Inderbitzi R, Hess R, Nachbur B, Stewart JC, Wang Q, Lim CK, Bonnett R, Berenbaum MC.
    Br J Cancer; 1991 Dec 15; 64(6):1116-20. PubMed ID: 1764375
    [Abstract] [Full Text] [Related]

  • 16. Experimental assessment of photodynamic therapy with chlorins for malignant mesothelioma.
    Ris HB, Giger A, Hof VI, Mettler D, Stewart JC, Althaus U, Altermatt HJ.
    Eur J Cardiothorac Surg; 1997 Oct 15; 12(4):542-8. PubMed ID: 9370396
    [Abstract] [Full Text] [Related]

  • 17. Effect of irradiation fluence rate on the efficacy of photodynamic therapy and tumor oxygenation in meta-tetra (hydroxyphenyl) chlorin (mTHPC)-sensitized HT29 xenografts in nude mice.
    Coutier S, Bezdetnaya LN, Foster TH, Parache RM, Guillemin F.
    Radiat Res; 2002 Sep 15; 158(3):339-45. PubMed ID: 12175311
    [Abstract] [Full Text] [Related]

  • 18. Photodynamic therapy for cancer of the upper aerodigestive tract using tetra(m-hydroxyphenyl)chlorin.
    Grosjean P, Savary JF, Mizeret J, Wagnieres G, Woodtli A, Theumann JF, Fontolliet C, Van den Bergh H, Monnier P.
    J Clin Laser Med Surg; 1996 Oct 15; 14(5):281-7. PubMed ID: 9612194
    [Abstract] [Full Text] [Related]

  • 19. Clinical pharmacokinetic studies of tetra(meta-hydroxyphenyl)chlorin in squamous cell carcinoma by fluorescence spectroscopy at 2 wavelengths.
    Braichotte D, Savary JF, Glanzmann T, Westermann P, Folli S, Wagnieres G, Monnier P, Van den Bergh H.
    Int J Cancer; 1995 Oct 09; 63(2):198-204. PubMed ID: 7591204
    [Abstract] [Full Text] [Related]

  • 20. Compartmental targeting for mTHPC-based photodynamic treatment in vivo: Correlation of efficiency, pharmacokinetics, and regional distribution of apoptosis.
    Garrier J, Bressenot A, Gräfe S, Marchal S, Mitra S, Foster TH, Guillemin F, Bezdetnaya L.
    Int J Radiat Oncol Biol Phys; 2010 Oct 01; 78(2):563-71. PubMed ID: 20656417
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.